Results 51 to 60 of about 147,677 (311)

Exploring new avenues: Psychedelic‐assisted therapy for young people

British Journal of Clinical Pharmacology, EarlyView.
Rates of mental illness in young people are increasing, whereas the development of novel mental health treatments has not significantly progressed. Psychedelic‐assisted therapy, using substances such as psilocybin and 3,4‐methylenedioxymethamphetamine (MDMA), has shown potential in the treatment of mental illnesses in the adult population, including ...
Ioanna Artemis Vamvakopoulou, Dasha Nicholls, David J. Nutt, Martina Di Simplicio   +3 more
wiley   +1 more source

Characteristics of Canadians who use vaping products, by smoking status: findings from the Canadian Community Health Survey, 2020

Health Promotion and Chronic Disease Prevention in Canada
IntroductionTo date, surveillance of vaping among Canadians (using vaping products with or without nicotine) has largely been examined with respect to age and smoking status.
Christine D. Czoli, Camille Guertin, Daniel Dubois, Nancy Farrell, Gabriella Luongo, Gillian Williams, Trevor Mischki   +6 more
doaj   +1 more source

The cannabis conundrum [PDF]

European Journal of Hospital Pharmacy, 2019
There is no doubt that the medicinal use of cannabis and cannabinoids is controversial. While there are few licensed products, there are plenty of chronic pain patients and parents of children with treatment resistant epilepsy who are convinced that cannabis derivatives help these conditions.
openaire   +2 more sources

Cannabis and cotton mouth

, 2022
Title from PDF caption (viewed on August 9, 2022).This archived document is maintained by the State Library of Oregon as part of the Oregon Documents Depository Program.

core  

Evaluation of a pantoprazole and 4‐desmethylpantoprazole‐sulfate metabolic ratio as a novel CYP2C19 phenotyping method

British Journal of Clinical Pharmacology, EarlyView.
Aims CYP2C19 is one of the most important pharmacogenes, and its activity is highly variable due to factors such as genetics or drug–drug interactions. Due to the lack of an appropriate endogenous CYP2C19 biomarker, surrogate methods to assess its activity are warranted.
Julian Peter Müller, Vladimir N. Belov, Sabrina Yamoune, Bob Miller, Mohammed Hasoumi, Jolanta Tupiec, Thea Laurentius, L. Cornelius Bollheimer, Julia C. Stingl, Katja S. Just   +9 more
wiley   +1 more source

Feasibility of medicinal cannabis cultivation in outdoor conditions using municipal reclaimed water

Journal of Cannabis Research
Increasing pressure on freshwater resources represents a major challenge for sustainable agricultural production in arid and semi-arid regions. In this context, the use of treated wastewater in agriculture may enhance environmental sustainability and ...
Tomás Bosco, Mariana Lozada, Mauricio Faleschini, Gregorio Bigatti   +3 more
doaj   +1 more source

Cannabis\u2010related allergies : an international overview and consensus recommendations

, 2022
: Cannabis is the most widely used recreational drug in the world. Cannabis sativa and Cannabis indica have been selectively bred to develop their psychoactive properties. The increasing use in many countries has been accelerated by the COVID-19 pandemic.
Klimek, Ludger, Poole, Jill. A., Ellis, Anne K., Skypala, Isabel J., Brucker, Hannelore, Zeiger, Joanna S., Connors, Lori, Nayak, Ajay P., Decuyper, Ine, Jeimy, Samira, Nanda, Anil, Goodman, Richard E., Murphy, Kevin R., Ebo, Didier, Silvers, William S., Bernstein, Jonathan A., Lo, Shun Chi Ryan, Walusiak\u2010Skorupa, Jolanta, Kanani, Amin, Sussman, Gordon   +19 more
core  

Cannabis use in young people. What kind of health promotion? [PDF]

, 2022
openIntroduzione: La cannabis è la sostanza illegale più utilizzata. In Italia, le stime più attendibili parlano di oltre sei milioni di consumatori.
CRIVELLARI, ANDREA
core  

Efficacy and safety of cannabinoids in the treatment of spasticity in multiple sclerosis: A systematic review of randomized clinical trials

British Journal of Clinical Pharmacology, EarlyView.
Aims This work aimed to evaluate the efficacy and safety of cannabinoids for the treatment of MS‐related spasticity. Methods Systematic searches were conducted in PubMed, EMBASE, and LILACS on 2 December 2025. Randomized controlled trials evaluating natural or synthetic cannabinoids for MS‐related spasticity were included.
Letícia Hamm‐Buiar, Daniela Gorski, Marcela Harumi Kagueiama, Astrid Wiens   +3 more
wiley   +1 more source

The medicalization of cannabis [PDF]

, 2010
Cannabis has been considered as both an illicit drug and a medicine throughout its history. Introduced to the UK as a medicine in the nineteenth century, its medical utility was limited and it was not until tetrahydrocannabinol (THC), one of the ...

core